Delta time spent in the open arm during the first time point of elevated plus maze before self admin vs after self admin
Tags: Behavior · Heroin · Elevated plus maze
Project: u01_peter_kalivas
2 loci · 2 genes with independent associations · 2 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | chr8 | 86716032 | 88108158 | 1 | 1 | 1.77e-07 | 1.45e-03 | 9.41e-02 | Ube3d |
2 | chr12 | 987892 | 2366974 | 1 | 1 | 3.08e-09 | 2.47e-02 | 9.08e-01 | Pcp2 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.06 |
Adipose | alternative TSS | 0 | 0 | 1 |
Adipose | gene expression | 1 | 0 | 0.97 |
Adipose | isoform ratio | 0 | 0 | 0.98 |
Adipose | intron excision ratio | 0 | 0 | 0.89 |
Adipose | mRNA stability | 0 | 0 | 0.97 |
BLA | alternative polyA | 0 | 0 | 1.08 |
BLA | alternative TSS | 0 | 0 | 1 |
BLA | gene expression | 0 | 0 | 0.96 |
BLA | isoform ratio | 0 | 0 | 0.96 |
BLA | intron excision ratio | 0 | 0 | 0.91 |
BLA | mRNA stability | 0 | 0 | 0.96 |
Brain | alternative polyA | 0 | 0 | 1.02 |
Brain | alternative TSS | 0 | 0 | 1.01 |
Brain | gene expression | 0 | 0 | 0.99 |
Brain | isoform ratio | 0 | 0 | 0.97 |
Brain | intron excision ratio | 1 | 0 | 0.99 |
Brain | mRNA stability | 0 | 0 | 0.97 |
Eye | alternative polyA | 0 | 0 | 0.88 |
Eye | alternative TSS | 0 | 0 | 1.05 |
Eye | gene expression | 0 | 0 | 0.9 |
Eye | isoform ratio | 0 | 0 | 0.85 |
Eye | intron excision ratio | 0 | 0 | 0.96 |
Eye | mRNA stability | 0 | 0 | 1.08 |
IL | alternative polyA | 0 | 0 | 1 |
IL | alternative TSS | 0 | 0 | 0.89 |
IL | gene expression | 0 | 0 | 0.96 |
IL | isoform ratio | 0 | 0 | 0.98 |
IL | intron excision ratio | 0 | 0 | 0.87 |
IL | mRNA stability | 0 | 0 | 0.94 |
LHb | alternative polyA | 0 | 0 | 0.97 |
LHb | alternative TSS | 0 | 0 | 0.86 |
LHb | gene expression | 0 | 0 | 0.93 |
LHb | isoform ratio | 0 | 0 | 0.89 |
LHb | intron excision ratio | 0 | 0 | 0.82 |
LHb | mRNA stability | 0 | 0 | 0.92 |
Liver | alternative polyA | 0 | 0 | 1.02 |
Liver | alternative TSS | 0 | 0 | 0.91 |
Liver | gene expression | 0 | 0 | 0.96 |
Liver | isoform ratio | 0 | 0 | 0.94 |
Liver | intron excision ratio | 0 | 0 | 0.9 |
Liver | mRNA stability | 0 | 0 | 0.95 |
NAcc | alternative polyA | 0 | 0 | 0.98 |
NAcc | alternative TSS | 0 | 0 | 1.08 |
NAcc | gene expression | 0 | 0 | 0.97 |
NAcc | isoform ratio | 0 | 0 | 0.97 |
NAcc | intron excision ratio | 0 | 0 | 0.95 |
NAcc | mRNA stability | 0 | 0 | 0.97 |
OFC | alternative polyA | 0 | 0 | 1.02 |
OFC | alternative TSS | 0 | 0 | 0.97 |
OFC | gene expression | 0 | 0 | 0.9 |
OFC | isoform ratio | 0 | 0 | 0.92 |
OFC | intron excision ratio | 0 | 0 | 0.84 |
OFC | mRNA stability | 0 | 0 | 0.97 |
PL | alternative polyA | 0 | 0 | 1.07 |
PL | alternative TSS | 0 | 0 | 0.98 |
PL | gene expression | 0 | 0 | 0.97 |
PL | isoform ratio | 0 | 0 | 0.98 |
PL | intron excision ratio | 0 | 0 | 0.96 |
PL | mRNA stability | 0 | 0 | 0.97 |
pVTA | alternative polyA | 0 | 0 | 0.97 |
pVTA | alternative TSS | 0 | 0 | 0.99 |
pVTA | gene expression | 0 | 0 | 0.97 |
pVTA | isoform ratio | 0 | 0 | 0.93 |
pVTA | intron excision ratio | 0 | 0 | 0.99 |
pVTA | mRNA stability | 0 | 0 | 0.96 |
RMTg | alternative polyA | 0 | 0 | 0.89 |
RMTg | alternative TSS | 0 | 0 | 0.94 |
RMTg | gene expression | 0 | 0 | 0.92 |
RMTg | isoform ratio | 0 | 0 | 0.88 |
RMTg | intron excision ratio | 0 | 0 | 1.06 |
RMTg | mRNA stability | 0 | 0 | 0.87 |